Toolkit/opto-iTrkB

opto-iTrkB

Construct Pattern·Research·Since 2019

Also known as: iLID opto-iTrkB

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

opto-iTrkB, also called iLID opto-iTrkB, is a blue-light-activated TrkB receptor tyrosine kinase construct built on the improved Light-Induced Dimerizer system. In the reported design, cytosolic inactive iLID-RTK is recruited to tdnano under blue light, which drives receptor dimerization and activates downstream ERK and Akt signaling.

Usefulness & Problems

Why this is useful

This construct enables optical control of TrkB pathway activation with light-dependent recruitment and dimerization rather than constitutive receptor activity. It is useful for studying RTK signaling dynamics because ERK and Akt activation was reported for opto-iTrkB only when the tdnano partner was present.

Problem solved

opto-iTrkB addresses the problem of controlling TrkB receptor activation with spatially and temporally defined light input. The reported design specifically solves how to keep the RTK monomeric and inactive in the dark, then activate it by blue-light-triggered recruitment to a dimerizing scaffold.

Problem links

Need conditional control of signaling activity

Derived

opto-iTrkB, also referred to as iLID opto-iTrkB, is a light-activated TrkB receptor construct built on the improved Light-Induced Dimerizer system. In the reported design, blue light recruits cytosolic, inactive iLID-RTK molecules to tdnano, driving receptor dimerization and enabling downstream ERK and Akt signaling.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Techniques

No technique tags yet.

Target processes

signaling

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: regulatorswitch architecture: recruitment

The construct uses the improved Light-Induced Dimerizer system and requires the tdnano component for reported signaling output. The evidence indicates that iLID-RTK is cytosolic in the dark and is recruited under blue light, but the supplied material does not provide additional construct architecture, expression, or delivery details.

The supplied evidence is limited to one 2019 source and provides only a brief activity statement for opto-iTrkB. Multi-day and population-level compatibility was stated for opto-iTrkA in PC12 cells, but equivalent validation was not provided here for opto-iTrkB.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 2activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 3activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 4activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 5activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 6activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 7activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 8activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 9activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 10activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 11activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 12activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 13activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 14activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 15activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 16activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 17activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 18compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 19compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 20compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 21compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 22compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 23compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 24compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 25compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 26compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 27compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 28mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 29mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 30mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 31mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 32mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 33mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 34mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 35mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 36mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 37mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 38mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 39mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 40mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 41mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 42mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 43mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 44mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 45mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 46mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 47mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 48targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 49targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 50targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 51targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 52targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 53targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 54targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 55targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 56targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 57targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination

Approval Evidence

1 source1 linked approval claimfirst-pass slug opto-itrkb
and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling

Source:

activitysupports

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.

Source:

Comparisons

Source-backed strengths

The source reports a clear dark-state mechanism in which iLID-RTK is cytosolic, monomeric, and inactive, which supports low basal signaling by design. It also reports that blue light with tdnano recruits two copies of iLID-RTK to drive dimerization and that opto-iTrkB reproduces downstream ERK and Akt signaling under these conditions.

Compared with eOPN3

opto-iTrkB and eOPN3 address a similar problem space because they share signaling.

Shared frame: same top-level item type; shared target processes: signaling

Compared with opto-iTrkA

opto-iTrkB and opto-iTrkA address a similar problem space because they share signaling.

Shared frame: same top-level item type; shared target processes: signaling; shared mechanisms: induced dimerization, light-induced recruitment, receptor tyrosine kinase activation

opto-iTrkB and tandem-dimer nano (tdnano) address a similar problem space because they share signaling.

Shared frame: shared target processes: signaling; shared mechanisms: induced dimerization, light-induced recruitment

Strengths here: looks easier to implement in practice.

Ranked Citations

  1. 1.

    Extracted from this source document.